Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Flexeril 20 mg at night?Clemastine fumarate brand name?Daridorexant synthesis steps?Qvar redihaler generic availability?Adderall hypertension?
See the DrugPatentWatch profile for Qulipta
Qulipta, a medication used for the preventive treatment of episodic migraine, can cause fatigue as a side effect [1].
Qulipta (atogepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist prescribed to reduce the frequency of migraine headaches in adults with episodic migraine [1].
As a CGRP receptor antagonist, Qulipta works by blocking the action of CGRP, a molecule that is thought to play a role in migraine [1].
Beyond fatigue, other common side effects of Qulipta can include nausea, indigestion, and upper respiratory tract infection [1].
Information regarding specific patent expiry dates for Qulipta is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patents and exclusivity periods [2]. Patent expiry can influence the availability of generic alternatives.
Other Questions About Qulipta :